Harrow Health Statistics
Share Statistics
Harrow Health has 36.7M
shares outstanding. The number of shares has increased by 0.66%
in one year.
| Shares Outstanding | 36.7M |
| Shares Change (YoY) | 0.66% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 58.34% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 65 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 4.16M, so 11.34% of the outstanding
shares have been sold short.
| Short Interest | 4.16M |
| Short % of Shares Out | 11.34% |
| Short % of Float | 14.34% |
| Short Ratio (days to cover) | 7.46 |
Valuation Ratios
The PE ratio is -68.42 and the forward
PE ratio is 18.99.
Harrow Health's PEG ratio is
1.97.
| PE Ratio | -68.42 |
| Forward PE | 18.99 |
| PS Ratio | 5.99 |
| Forward PS | 1.7 |
| PB Ratio | 0 |
| P/FCF Ratio | -19.65 |
| PEG Ratio | 1.97 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Harrow Health.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | 0 |
| Quick Ratio | 0 |
| Debt / Equity | 0 |
| Debt / EBITDA | 11.87 |
| Debt / FCF | -3.76 |
| Interest Coverage | 0.39 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $522,549.74 |
| Profits Per Employee | $-45,761.78 |
| Employee Count | 382 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 4.6 |
Taxes
| Income Tax | -161B |
| Effective Tax Rate | 892362.27% |
Stock Price Statistics
The stock price has increased by 68.47% in the
last 52 weeks. The beta is 0.41, so Harrow Health's
price volatility has been higher than the market average.
| Beta | 0.41 |
| 52-Week Price Change | 68.47% |
| 50-Day Moving Average | 25.6 |
| 200-Day Moving Average | 35.43 |
| Relative Strength Index (RSI) | 62.11 |
| Average Volume (20 Days) | 555,682 |
Income Statement
In the last 12 months, Harrow Health had revenue of 199.61M
and earned -17.48M
in profits. Earnings per share was -0.49.
| Revenue | 199.61M |
| Gross Profit | 150.37M |
| Operating Income | 8.82M |
| Net Income | -17.48M |
| EBITDA | 19.28M |
| EBIT | 5.47M |
| Earnings Per Share (EPS) | -0.49 |
Full Income StatementBalance Sheet
The company has 47.25M in cash and 228.83M in
debt, giving a net cash position of -181.58M.
| Cash & Cash Equivalents | 47.25M |
| Total Debt | 228.83M |
| Net Cash | -181.58M |
| Retained Earnings | -151,385B |
| Total Assets | 364.16M |
| Working Capital | -17.45M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -22.2M
and capital expenditures -38.67M, giving a free cash flow of -60.88M.
| Operating Cash Flow | -22.2M |
| Capital Expenditures | -38.67M |
| Free Cash Flow | -60.88M |
| FCF Per Share | -1.71 |
Full Cash Flow StatementMargins
Gross margin is 75.33%, with operating and profit margins of 4.42% and -8.76%.
| Gross Margin | 75.33% |
| Operating Margin | 4.42% |
| Pretax Margin | -9.04% |
| Profit Margin | -8.76% |
| EBITDA Margin | 9.66% |
| EBIT Margin | 4.42% |
| FCF Margin | -30.5% |
